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Type to Improve Health in Type 2 




Intermittent fasting (IF) is the cycling between periods of eating and fasting. 
The two most popular forms of IER are: the 5: 2 diet characterized by two con-
secutive or non-consecutive “fast” days and the alternate-day energy restriction, 
commonly called alternate-day fasting (ADF). The second form is time-restricted 
feeding (TRF), eating within specific time frames such as the most prevalent 16: 8 
diet, with 16 hours of fasting and 8 hours for eating. It is already known that IF can 
bring about changes in metabolic parameters related with type 2 diabetes (T2D). 
Furthermore, IF can be effective in improving health by reducing metabolic disor-
ders and age-related diseases. However, it is not clear yet whether the age at which 
fasting begins, gender and severity of T2D influence on the effectiveness of the dif-
ferent types of IF in reducing metabolic disorders. In this chapter I will present the 
risk factors of T2D, the different types of IF interventions and the research-based 
knowledge regarding the effect of IF on T2D. Furthermore, I will describe several 
machine learning approaches to provide a recommendation system which reveals a 
set of rules that can assist selecting a successful IF intervention for a personal case. 
Finally, I will discuss the question: Can we predict the optimal IF intervention for a 
prediabetes patient?
Keywords: machine learning, decision tree, type 2 diabetes, insulin resistance, 
precision medicine, intermittent fasting
1. Introduction
Obesity is an epidemic in developed countries. The obesity epidemic is 
increasing its magnitude and its public health impact. In 2017–2018, 67% of the 
population in Australia were overweight or obese [1]. In the United States, only 
minority of the individuals have a healthy weight (body mass index (BMI) of 
18.5–25 kg/m2, [2]. Furthermore, according to the World Health Organization 
(WHO), nearly 2 billion adults are overweight and more than 600 million 
patients are obese [3]. Type 2 Diabetes (T2D) is one of the chronical diseases 
associated with Obesity. T2D is usually characterized by insulin resistance (IR) 
[4]. Insulin resistance (IR) happens when the body does not fully respond to 
insulin. IR level can be used as a filtering index for primary T2D prevention.  
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IR can be measured by using the homeostatic model assessment of insulin 
resistance (HOMA-IR) equation. HOMA-IR can be evaluated by fasting glucose 
and insulin levels. People with T2D commonly have High HOMA-IR score, which 
indicates significant insulin resistance [5–7].
As little as 3% weight reduction produces clinically significant effects to reduce 
HOMA-IR [8, 9]. The most widely prescribed strategy to induce weight loss is to 
reduce the daily calory intake [10]. Current guidelines recommended continuous 
energy restriction (CER) along with comprehensive lifestyle intervention, as the 
cornerstone of obesity treatment [11]. For some individuals CER are effective for 
weight loss. However, many people realize that this type of diet is difficult to follow, 
as it requires robust calorie counting, and frustration is caused be owing to the feel-
ing of never being able to eat freely.
There has been increased interest in identifying alternative dietary weight loss 
strategies, because of the relative ineffectiveness of traditional CER approaches for 
achieving and sustaining weight loss. One such approach is intermittent fasting (IF) 
also called intermittent energy restriction (IER) which encompasses various diets 
that cycle between periods of fasting and no fasting, these diets do not necessarily 
specify what to eat. The regimens of IER may be easier to follow and maintain over 
time than CER. Furthermore, people do not fully compensate during fed periods for 
the lack of energy created during prolonged periods of fasting. Therefore, IER may 
lead to metabolic adjustments that prefer greater fat mass loss, better maintaining 
of lean mass, and weight loss [12–13].
The IER regimens range from fasting the whole days at a time to fasting for 
several hours during the day. IER paradigms involve recurring periods with little 
or no energy intake with intervening periods of ad libitum food intake. The two 
most popular forms of IER are: the 5: 2 diet characterized by two consecutive or 
non-consecutive “fast” days and the alternate-day energy restriction, commonly 
called alternate-day fasting (ADF). The second form is time-restricted feeding 
(TRF), eating within specific time frames such as the most prevalent 16: 8 diet, with 
16 hours of fasting and 8 hours for eating.
Previous studies and systematic reviews provide an overview of IER regimes 
[14–34]. Those studies report the health benefits leading by IER regimes and discuss 
the physiological mechanisms by which health outcomes might be improved [35]. 
However, the question of whether IER is always able to reduce HOMA-IR is not 
answered by the latter studies; In other words, what are the conditions (age, gender, 
basal fasting glucose level, etc.) needed to make the IER effective for reducing 
HOMA-IR have not yet been deciphered. Moreover, results of previous studies are 
reported on a group level only rather than report per individual.
In today’s era of precision medicine, we can be motivated to answer the ques-
tion Can we predict who will be Successful on an IMF or TRF Diet or CER? For 
example, a patient with prediabetes or diabetes comes to see his physician to ask for 
advice. Could such patient benefit from a specific IF intervention? Benefit in terms 
of reducing HOMA-IR or even eliminating the T2D altogether. A recommendation 
system which suggest effective IF intervention for a certain patient is found in a new 
study [36]. The recommendation system is based on individual data from human 
fasting intervention studies. The system presented in the study, predicts which type 
of IF treatment can improve an individual’s health and preventing or curing T2D. A 
machine learning approach is used to develop the recommendation system while a 
set of rules which can assist individual patients and their physicians in selecting the 
best IF intervention is provided by the results of the study.
A further question will be discussed in this chapter: Can we predict the optimal 
intervention IMF or TRF Diet or CER or other for a prediabetes patient? and what is 
the accuracy of such prediction?
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2. Type 2 diabetes (T2D)
Diabetes is a chronic, metabolic disease characterized by elevated levels of blood 
glucose (or blood sugar). Our metabolism converts food into energy for our bodies 
to use. One of the things needed for this process is insulin. The pancreas makes a 
hormone called insulin. The insulin helps the cells turn glucose from the food we eat 
into energy. After we eat, the sugar levels in our blood rise and insulin is released 
into the bloodstream. The insulin then makes the cells absorb sugar from the blood. 
If this process does not work properly, the blood sugar levels rise. The medical term 
for blood sugar levels that are too high is hyperglycemia.
According to the International Diabetes Federation in 2017 there were 425 mil-
lion people in the world with diabetes. That is close to 1 in 11 people [37].
2.1 Main types of diabetes
There are two main types of diabetes: type 1 and type 2. Glucose gives the body 
cells energy, but to enter the cells it needs insulin. People with type 1 diabetes do 
not produce insulin; while people with T2D do not respond to insulin as well as they 
should. Both types of diabetes can lead to chronically high blood sugar levels. Type 1 
diabetes usually develops in childhood or teenage years. This disease is a result of 
damage to the pancreas that leaves it producing either very little insulin or none. 
Type 1 diabetes is caused by an autoimmune reaction where the body’s defense 
system attacks the cells that produce insulin. Things are different in T2D, where 
insulin is made by the pancreas, but the body’s cells lose the ability to absorb and use 
the insulin. In people who have T2D, the pancreas produces enough insulin, but it 
no longer influences the body’s cells. The medical term for this is “insulin resistance” 
(IR). The pancreas can compensate for this for a while by producing more insulin. But 
at some point, it can no longer keep up, and then blood sugar levels start to rise. T2D 
is characterized by (IR), where the body does not fully respond to insulin. In the past, 
T2D was often referred to as “adult-onset” diabetes because it is commonly diagnosed 
later in life. T2D is much more common than type 1 diabetes. Among all the people 
living with diabetes, 90–95% percent have T2D. This chapter focuses on T2D.
2.2 Causes and risk factors
Usually, a combination of things causes T2D. There are several gene mutations 
linked to diabetes. Not everyone who carries a mutation will get diabetes. However, 
many people with diabetes do have one or more of these mutations. Being overweight 
or obese can cause IR. People with insulin resistance often have a group of conditions 
commonly called “Metabolic syndrome”, including high blood sugar, extra fat around 
the waist, high blood pressure, high cholesterol and high triglycerides. Another cause 
can be bad communication between cells. Sometimes, cells send the wrong signals or 
do not pick up messages correctly. When these problems affect how cells make and 
use insulin or glucose, a chain reaction can lead to diabetes. Finally, broken beta cells 
can cause diabetes since if the cells that make insulin send out the wrong amount of 
insulin at the wrong time, blood sugar is not controlled properly.
Various factors can increase the likelihood of developing T2D. They can be 
described using 3 categories. The category of risk factors is who you are: age of 45 
or older, a family relative with diabetes or ethnicity. The second category is health 
and medical history: being prediabetes can increase the risk for diabetes, heart 
and blood vessel disease, high blood pressure, low HDL (“good”) cholesterol, 
high triglycerides, being overweight or obese, Gestational diabetes while you were 
pregnant and finally depression. The last category of risk factors is the daily habits 
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and lifestyle. Among this category we can find factors such as getting little or no 
exercise, smoking, stress or sleeping too little or too much.
2.3 Symptoms and complications
T2D can evolve moderately during several years. Blood sugar levels stay high all 
the time when T2D is untreated. High blood sugar levels may cause the following 
symptoms: thirstiness, frequent urination, tiredness and apathy, fulsomeness and 
dizziness or even lose consciousness. In addition to T2D symptoms there are compli-
cations of T2D containing, five times more likely to get heart disease or have a stroke, 
dialysis, or kidney replacement in case the kidneys are damaged. Furthermore, high 
blood sugar can damage the small blood vessels in the backs of the eyes and in cases 
of neglect, it can cause blindness. Digestive disorders, not feeling of the feet and 
sexual response are considered as T2D complications as well. Lesions cure slower and 
can become infected when blood does not circulate well. Miscarriage are more likely 
in women with diabetes. A condition in which breathing stops and starts while you 
sleep might developed. It is more likely to have hearing problems. Finally, high blood 
sugar can damage your brain and might put you at higher risk of Alzheimer’s disease.
2.4 How does T2D diagnosed?
Hemoglobin is a protein that transports oxygen to the body cells. It can be found 
inside red blood cells. In cases of high glucose level in the blood glucose can attach 
the hemoglobin. Hemoglobin that is attached to glucose is called glycated hemo-
globin. T2D diabetes is usually diagnosed using the A1C test. A1C test measures the 
amount of hemoglobin in the blood that has glucose attached to it.
Red blood cells are constantly dying and regenerating. Their lifespan is approxi-
mately three months. Glucose attaches (glycates) to hemoglobin inside the red 
blood cells, so the record of how much glucose is attached to the hemoglobin also 
lasts for about three months. Normally, about 6 percent of hemoglobin has glucose 
attached. If there is too much glucose attached to the hemoglobin cells, the test 
results will be high A1C. If the amount of Glycated hemoglobin amount is normal, 
the A1C results will be normal. An A1C level of 6.5 percent or higher on two separate 
tests means you have diabetes.
The symbol A1C represents a specific type of hemoglobin. The “A” in 
Hemoglobin A (HgbA) stands for “adult.” HgbA can be found in two types HgbA1 
and HgbA2. In individuals from six months old about 98% of HgbA is type 1 
(HgbA1). Type A1 has subtypes A1A, A1B, A1C, and others. Two-thirds of hemo-
globin with glucose attached is type A1C [38]. Therefore, HgbA1C is a good marker 
for glucose control. Larger amount of hemoglobin will be glycated when more 
glucose is circulating in the blood.
However, the A1C test results are not always meaningful. For example, when 
we want to measure A1C difference before and after an intervention that is shorter 
than three months. The difference of A1C before and after the intervention will not 
tell us the accurate result because it is an average calculation. In such case we need 
another test to diagnose the glucose level in blood. Fasting blood glucose test is a 
blood sample which is taken after an overnight fast. A normal level of fasting glu-
cose is a reading of less than 100 mg/dL (5.6 mmol/L). If the fasting blood glucose is 
126 mg/dL (7 mmol/L) or higher, it considered diabetes. Values between 100 to 125 
considered prediabetes. T2D is generally characterized by insulin resistance, where 
the body does not fully respond to insulin.
HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. 
Using HOMA-IR equation insulin resistance can be estimated from fasting glucose 
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and insulin levels. High score of HOMA-IR indicates a significant Insulin resis-
tance which usually found in people with Diabetes Type 2. An updated HOMA 
model (HOMA2) was published by Jonathan Levy in 1998. HOMA2 model took 
account of variations in hepatic and peripheral glucose resistance, increases in 
the insulin secretion curve for plasma glucose concentrations above 10 mmol/L 
(180 mg/dL) and the contribution of circulating proinsulin [39]. In 2004, the 
HOMA2 Calculator [40] was released by Oxford university UK. This provides 
quick and easy access to the HOMA2 model for researchers who wish to use 
model-derived estimates of Insulin resistance, rather than linear approximations 
as provided by HOMA-IR model. There are additional tests to diagnose Diabetes 
type 2,beside those mentioned here, however those methods will not be discussed 
further in this chapter.
2.5 How is T2D treated?
There are two approaches to treat T2D. The first is lifestyle changes and the sec-
ond is medications. Adopting a healthy lifestyle can help lower the risk of diabetes. 
Healthy life style contains: lose weight, get active, eat right, avoid highly processed 
carbs, sugary drinks, and trans and saturated fats, limit red and processed meats, 
quit smoking and finally work to keep from gaining weight after you quit smoking, 
so you do not create one problem by solving another. It is possible to reach your 
target blood sugar levels with diet and exercise alone. However, if changing lifestyle 
is not enough several medicines exist to treat diabetes. Among the medicine func-
tions are: Lowering the amount of glucose your liver makes and helps your body 
responding better to the insulin. Helping your body make more insulin, making you 
more sensitive to insulin. Causing slow digestion and lowering blood sugar levels 
and finally help your kidneys filter out more glucose.
3. Intermittent fasting
In historical periods in the past when food was not always available fasting was 
sure to happen. Many religious philosophies have practiced fasting for centuries; 
however, cyclically restricting or reducing calories has recently taken off as a way to 
lose weight and improve health outcomes. Intermittent fasting (IF) is proposed as 
an alternative dieting strategy. IF includes cycles of fasting and unrestricted eating 
periods, which may allow more flexibility and thereby enhance devoutness [41]. 
Intermittent fasting is generally grouped into two main categories: whole-day fast-
ing and time-restricted feeding. Both categories range in flexibility of time spent 
fasting. The details of intermittent fasting interventions which participate in the 
research described in this chapter are found in the following subsections.
3.1 Continuous energy restriction (CER)
In a paper from 2011 [42] Michelle Harvie describes a randomized controlled 
trial to compare the feasibility and effectiveness of intermittent continuous energy 
(IER) with continuous energy restriction (CER) for weight loss, insulin sensitivity 
and other metabolic disease risk markers. The CER involved a 25% energy restric-
tion from estimated baseline energy requirements using reported metabolic energy 
turnovers estimated basal metabolic rate [43] for 7 days per week. The CER group 
was prescribed a daily 25% restriction based on a Mediterranean-type diet (30% 
fat, 15% monounsaturated, 7.5% saturated fat, 7.5% polyunsaturated fatty acids, 
45% low glycemic load carbohydrate and 25% protein) [44].
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3.2 Intermittent energy restriction (IER)
The IER group from the randomized controlled trial in Harvie’s paper [42] 
took a very low-calorie diet (VLCD) (75% restriction) on two consecutive days 
and for the remaining 5 days consume food for weight maintenance. The VLCD 
provided 2700 kJ of energy and 50 g protein per day, four portions of vegetables 
(~80 g per portion), one portion of fruit, a salty low-calorie drink and a mul-
tivitamin and mineral supplement. The duration of the intervention was six 
months.
3.3 Daily morning fasting (DMF)
Daily morning fasting is based on the Bath Breakfast Project (BBP) [45]. BBP is 
a randomized controlled trial comparing the effects of daily breakfast consumption 
relative to extended fasting on energy balance and human health. In a randomized 
cross-over design, obese men and women extended their overnight fast by omit-
ting breakfast consumption or ingesting a typical carbohydrate-rich breakfast of 
(521 ± 94 kcal), before an ad libitum pasta lunch 3 h later. The duration of interven-
tion was 4 weeks.
3.4 Fasting every second day (FESD)
Fasting every second day (FESD) was experienced in a paper of Nils Halberg 
[46]. The duration of the intervention was 14 days of fasting every second day for 
20 h, giving seven fasting periods. Each fasting period started at 22:00 and ended at 
18:00 the following day. During the fasting periods, the subjects could drink water 
and were instructed to maintain habitual activities.
3.5 Intermittent energy and carbohydrate restriction (IECR)
Another IER approach is tested in the paper of Michelle Harvie from 2013 
[47]. The test in latter paper included two intermittent energy and carbohydrate 
restriction (IECR) regimens, including one which allowed ad libitum protein and 
fat (IECR PF). Overweight 115 women were randomized to an overall 25% energy 
restriction, either as an IECR (2500–2717 kJ/d,40 g carbohydrate/d for 2 d/week) 
or a 25% daily energy restriction (DER – which is type of CER - approximately 
6000 kJ/d for 7 d/week) or an IECR PF for a 3-month weight-loss period and 
1 month of weight maintenance (IECR or IECR PF for 1 d/week).
4. The steps in machine learning
This study described in this chapter aims to predict whether a specific IF 
intervention would reduce the insulin resistance of an individual with predia-
betes. The approach to answer this question is machine learning. The process 
of machine learning is composed of 5 major steps: The first is identifying the 
required data and gathering data from various sources. The next step is preparing 
and Pre-processing the data to have homogeneity. Then the model must be built 
by selecting the right Machine Learning classifier. The fourth step is to train and 
test the data and gain insights from the model results. Finally, we might want to 
improve results by feature selection for example.
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4.1 Identifying required data
In order to answer the question of this study, authors of 25 published papers that 
performed randomized clinical trials investigating the IF effects on T2D parameters 
were asked for the individual data. I received the individual data from 5 out 25 
papers [42, 45–48]. The other authors replied that they could not submit the data 
due to the confidentiality of the participants.
4.2 Processing the data
4.2.1 Choosing people
The selection criteria for this research were: basal fasting glucose above 5 mmol/L 
(90 mg/dL) or BMI (Body Mass Index) above or equal to 25. Those criteria were estab-
lished since they indicate possible prediabetes [49]. The IDF’s 2019 cutoff for fasting 
glucose indicating prediabetes is 100 mg/dL; we set the cutoff at 90 mg/dL. Finally, 254 
individuals who answered the criteria were selected. Table 1 contains the average values 
of the numerical attributes of the data. The average values show decrease in weight, 
BMI, fasting glucose and fasting insulin however we should remember that those are 
averages therefore we cannot conclude that all the interventions work all the time for all 
the people. This would be the query that the machine learning approach will investigate.
4.2.2 HOMA-IR equation
The Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) has been 
proven to be a very sensitive test for indicating prediabetes [8]. Insulin resistance 
can be estimated from fasting glucose and insulin levels. This is shown in the 
HOMA-IR equation presented as follows:
 IR− = ∗HOMA Fasting Glucose Fasting Insulin  (1)
Prediabetes people or people with T2D usually have a significant insulin resistance. 
A high score of HOMA-IR indicates a significant insulin resistance. To learn the differ-
ence of HOMA-IR before and after the intervention the HOMA-IR using (Eq. (1)) was 
calculated twice for each of the 254 individuals. Once HOMA-IR was calculated for the 
basal values of fasting glucose and insulin and once for the values after the intervention. 
The difference between them represents the insulin resistance reduction.
4.2.3 Types of intermittent fasting interventions
This study contains 9 different types of interventions, starting from continuous 
energy restriction – through intermittent energy restriction for two days a week, or 




Basal After Basal After Basal After Basal After
44.3 87.5 81.1 32.1 31 4.99 4.93 61.1 53.6
Table 1. 
Average values of attribute in selected data.
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daily morning fasting or fasting every second day. Part of the interventions con-
tained specific diets. The names of the different types of the interventions and their 
description are found in Table 2 below.
Table 2 summarizes the different IF regimens included in this study. The refer-
ence to each regimen is also shown in Table 2 for further details.
4.2.4 Individual’s features
The data collected for each individual in this study contained details regarding 
the age, gender, weight, ethnicity, basal BMI, basal fasting glucose, fasting glucose 
after intervention, basal fasting insulin and fasting insulin after intervention. 
Details of the intervention such as intervention’s name and duration were also 
included for each individual. For being able to train and learn from the data the 
features ‘fasting glucose after intervention’ and ‘fasting insulin after intervention’ 
must be excluded. A calculated feature named ‘HOMA-IR difference’ was added 
to the training vector. This feature was calculated as follows: if the intervention is 
successful we expect a reduction in HOMA-IR; thus, if the HOMA-IR difference 
is greater than zero the assignment in the ‘HOMA-IR difference’ column is set to 
TRUE otherwise it is FALSE. The final training vector included the ten following 
features: age, gender, weight, ethnicity, basal BMI, basal fasting glucose, basal fast-
ing insulin, intervention’s name, intervention’s and HOMA-IR difference.
4.3 Building a model from the data
The problem of the study describe here is a classification question. Can we pre-
dict whether an intermittent fasting intervention will be useful to improve T2D risk 
parameters for a certain individual? Classification is a data mining technique which 
solve problems by analyzing large volumes of data. Furthermore, classification is 
the process of finding a model that describes and differentiates data classes, where 
the ultimate goal is being able to use the model to predict the class of an instance 
whose label is unknown. Decision trees are kind of algorithm that can be used for 






CER Continuous energy restriction - 7 days a 
week trail
CER 24 weeks [42]
IER Intermittent energy restriction - 2 days a 
week trail
IER 24 weeks [42]
DMF Daily Morning Fasting IER 4 weeks [45]
FESD Fasting Every Second IER 2 weeks [46]
IECR Intermittent Energy and Carbohydrate 
Restriction
IER 24 weeks [47]
IECR+PF Intermittent Energy and Carbohydrate 
Restriction + free protein and fat
IER 24 weeks [47]
DER Daily Energy Restriction CER 24 weeks [47]
High Carb High Carbohydrate weight loss diet CER 12 weeks [48]
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neural networks, naïve bayes, logistic regression and others. However, the decision 
tree classification with the Waikato Environment for Knowledge Analysis (Weka) 
is the simplest way to mine information from a database. Furthermore, decision 
trees can deal with a large variety of feature types like binary, nominal, ordinal, 
categorial and numeric like those found in our mixed dataset [50]. Finally, decision 
trees are an intuitive way of representing a sequence of rules that lead to a class or 
value. The decision tree output is a flowchart-like tree structure. The decision tree 
algorithms J48, LMT (Logistic Model Tree), Random Forest and Random Tree as 
well as the Logistic Regression and Naïve Bayes classifiers were tested on the data in 
this study.
4.4 Training and testing
The next step was training the dataset (254 individuals) and building models 
using six different classifiers: J48 decision tree, Logistic Model Tree, Random 
forest, Random tree, Logistic and Naïve Bayes. The optimal number of features 
as a function of sample size is proportional to √n (n is the sample size) for highly 
correlated features [51]. The features in the study shown here are highly correlated 
and √254 = 15.9 while the number of features is 9 (i.e. 9 attributes for 254 individu-
als is reliable). Following the training comes the testing. Two test approaches were 
selected to validate the model – the leave-one-out and the 10-fold cross validations. 
In the leave-one-out approach you test every individual by excluding it from the 
training set, train the 253 left individuals and then test the excluded one. This 
happens 254 times, namely for every individual in the dataset. The 10-fold cross 
validation test approach divide the dataset into 10 groups equal in size. Then for 
ten times train and build the model with nine of the groups together and test the 
individual found in the 10th excluded group.
5. Decision rules for health benefit due to intermittent fasting
5.1 Prediction whether HOMA-IR decreases
When measuring performance of machine learning classifiers, accuracy is not 
enough. For comparing results from different classifiers, we need an additional 
measure. The additional measure is based on the definition of four groups resulted 
when solving a classification. For example, in our case when the case is that there is 
a reduction in HOMA-IR then the TRUE-POSITIVE (TP) group is when the predic-
tion is correct, while the FALSE-POSITIVE (FP) group is when the prediction is not 
correct. The two additional groups found when the case is that there is no HOMA-IR 
reduction then TRUE-NEGATIVE (TN) will be when the prediction is false in other 
words the prediction is correct; however, when the prediction is not correct we say it 
is the FALSE-NEGATIVE (FN). The additional measure to compare between different 
classifiers is Area Under Curve (AUC) measure. AUC presents the relation between 
the TP rate and the FP rate and it is a very useful in the comparison between classi-
fiers. The value of AUC ranges between 0 to 1. AUC equals 1 means a perfect classifier 
TP = 1 and FP = 0, while random classifier is when AUC is equal approximately to 0.5.
The AUC of the six different classifiers – J48, LMT, Random Forest, Random 
Tree, Logistic Regression and Naïve Bayes using the two test methods mentioned 
in the previous paragraph – are shown in Table 3. The AUC of the 10-Fold test 
is shown in the first row of Table 3 while the Leave-One-Out test is found in the 
second row. For both tests the AUC differences between the classifiers are very 
small (0.67 to 0.75 in the 10-fold and 0.65–0.8 in the leave-one-out); we therefore 
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Figure 1. 
Sub-decision tree – Male side.
conclude that all six classifiers perform similarly. The advantage of Random Forest 
is to prevent overfitting by creating random subsets of the features and building 
smaller trees and then combining the subtrees, however J48 is shown to yield the 
most accurate prediction within the decision tree algorithms [50]. In addition, J48 
explains itself and easy to follow. In the J48 decision tree, the internal nodes are the 
different features (age, gender, weight, etc.), the branches between the nodes rep-
resent the possible values that these features may have (age: lower than 18 or equal 
higher than 18, gender: male/female, etc.). The terminal nodes tell us the final value 
of the prediction(TRUE or FALSE assigned for HOMA-IR difference). As shown 
in Table 3 using J48 classifier and the 10-fold cross validation test the model AUC 
is 0.7. Furthermore, the Leave-One-Out test achieves AUC of 0.8. Therefore, the 
J48 model successfully predicts whether an intervention would help an individual 
improve his T2D risk parameters by reducing HOMA-IR.
The visualization of the J48 decision tree is found in Figures 1–4. Interestingly 
the attribute gender is the first node in the tree, as shown in Figures 1 and 2.  
Having the gender as the first splitting attribute indicates that this attribute is 
the most informative one for the decision. Moreover, for males the duration of 
the intervention is the most important attribute to decide the effectiveness of the 
intervention (Figure 1); while for females the basal fasting insulin level is reported 
as the most important feature (Figure 2). Green in Figures 1–4 represents TRUE 
which indicates success in reducing HOMA-IR while red represents FALSE which 
indicates no reduction.
Analyzing the sub-decision tree of the males’ side shown Figure 1, brings to 
the conclusion that men are indifferent to the type of the intervention rather they 
affected by the duration of the intervention. Success of intervention defined by 
reducing HOMA-IR, can be achieved by short duration of fasting (less or equal to 
2.5 weeks) and lower BMI (less or equal to 25.8) or long duration of intervention 
and age 41 years and younger. Reasonably, attributes like lower BMI and younger 
age make it easier to reduce HOMA-IR.




10-Fold 0.7 0.75 0.75 0.67 0.79 0.73
Leave-One- Out 0.8 0.74 0.74 0.66 0.79 0.72
Table 3. 
AUC for different classifiers.
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Unlike the male side of the decision tree, in the female side the type of intervention 
is part of the tree and is represented by the nodes of the tree. As shown in Figure 2 
the intervention are nodes of the tree which are colored yellow while the nodes that 
represent attributes are colored blue. Moreover, the view of the tree on the female 
side consist of many different and connected parts compared with the male side 
of the tree. The fact that there are more women in the dataset than men can be the 
reason for this complexity view. The different interventions are part of the decision 
nodes as shown in Figure 2. The different interventions are arranged hierarchically 
Figure 2. 
Sub-decision tree – Female side.
Figure 3. 
Sub-decision tree – Female left side.
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starting with DMF followed by IECR or beginning with IECR followed by the Hi 
Mono diet. The success of the different interventions in improving HOMA-IR is 
shown in Figure 3. The hierarchical structure of the interventions is organized by 
their success, beginning with DMF, IECR and then IECR+PF. An interesting evi-
dence which should be further investigated is found in Figure 4. That evidence is the 
node where lower BMI leads to an unsuccessful intervention.
5.2 Testing separately the reduction of fasting glucose or fasting insulin
To find out whether only fasting glucose reduction or fasting insulin reduction 
taken separately instead of HOMA-IR can be used to predict the usefulness of an 
intervention two additional train and test process were done. Table 4 summarizes 
the results of the predictions based once only on fasting glucose reduction and once 
only on fasting insulin reduction.
As shown in Table 4 the prediction of improvement in T2D based on HOMA-IR 
is more effective than the prediction based on fasting glucose or the fasting insulin 
separately. As shown in Eq. 1, the HOMA-IR calculation is based on both fasting 
glucose and fasting insulin.
5.3 Comparing results with random classification
An interesting question would be would these results based on HOMA-IR 
obtain on random? To answer this question, I reordered the values in the HOMA-IR 
column in an arbitrary way. The ratio between the TRUE values and the FALSE 
values was identical to the original column. The AUC results of training and testing 
Figure 4. 
Sub-decision tree – Female right side.
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with random data were much lower compared with the original data. The 10-Fold 
cross validation test yields 0.56 AUC compared with 0.7 in the original data. The 
Leave-One-Out test difference in AUC between the random and the original data 
was even more significant – 0.61 AUC in the random data compared with 0.8 in the 
original data. Those results answer the question asked above and suggest that the 
model predictions cannot be obtain in random.
5.4 Testing features redundancy
Another interesting question is whether all the features mentioned in 4.2.4 are 
needed for the prediction. To test this a feature selection test was performed on the 
data. In each test a different feature was excluded. The AUC results are shown in 
Table 5.
The feature in every row of Table 5 except of the first row, is excluded and AUC 
is calculated without this feature. None of the features is redundant since as shown 
in Table 5 the highest AUC is shown when all features are trained.
6. Conclusions
To achieve steady-state fasting levels for many metabolic substrates which 
are found in blood draws taken from patients, the patients are required to fast 
8–12 hours. This evidence can show us that even a single fasting interval in humans 
(e.g., overnight) can reduce basal concentrations of metabolic biomarkers related 
with T2D, such as insulin and glucose. Intermittent fasting regimens may be a 
promising approach to losing weight and improving metabolic health. Moreover, 
these eating regimens may offer promising nonpharmacological approaches to 







10-Fold Cross Validation 
test
0.7 0.6 0.55
Leave- One-Out test 0.8 0.6 0.6
Table 4. 
Summary of AUC results for improving T2D risk parameters.






Basal BMI 0.69 0.77
Fasting Glucose – basal 0.65 0.73
Fasting Insulin – basal 0.62 0.6
Table 5. 
Features selection – AUC results of J48 Decision tree.
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The question in this study is not how to lose weight but to answer the question of 
which of the people suffering from T2D can benefit through an intermittent fasting 
approach and what is the best type of intermittent fasting for a particular person. 
This it offers a recommendation system based on data from several clinical trials for 
answering those questions. The recommendation system selects the optimal inter-
vention to improve the health of prediabetes individuals or people with T2D. The 
improvement in health reflected in reducing their glucose and insulin levels which 
are considered T2D risk parameters and composed the HOMA-IR equation. The 
procedure in this study is built using a machine learning approach and is the results 
are presented by a decision tree. The conclusions from the decision rules derived 
from the tree are that males and females have a different set of rules because the 
node gender comes first in the tree. The success of intervention in males depends on 
the duration of the IF. Therefore, males are indifferent to the type of intervention. 
Moreover, males with a smaller BMI will be more likely to have a successful inter-
vention in case the duration of intervention is equal or less than 2.5 weeks. On the 
other hand, if the duration of the intervention is more than 2.5 weeks for males than 
age will be important to its success. Reasonably, younger age will serve as a benefit. 
The level of basal fasting insulin is the most important attribute for a successful 
intervention in female. There are some cases where no intervention within the 
dataset of this study can assist in improving HOMA-IR for example if a female with 
a basal fasting insulin equal or less than 37.1 pmol/L (for moderate insulin resistance 
the fasting insulin should be in the range of 18–48 pmol/L) and age exceeding 52.
To apply for a wider population additional clinical trail’s data should be used. 
Moreover, a larger dataset will make it possible, to build a software which would 
assist physicians in advising an optimal intervention to their patients and by that 
providing a better personalized medical service to their patients.
Acknowledgments
I wish to thank Michelle Harvie, Nils Halberg, Flemming Dela, Peter M. Clifton, 
Eric Ravussin, Leonie Kaye Heilbronn and Enhad Chowdhury for their assistance in 
this study by sending the individual data from their published clinical trial papers.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
15
Selecting Intermittent Fasting Type to Improve Health in Type 2 Diabetes: A Machine Learning…
DOI: http://dx.doi.org/10.5772/intechopen.95336
[1] Australian Bureau of Statistics. 
National Health Survey: First Results, 
2017-2018 [Internet]. Canberra (ACT): 
Commonwealth of Australia; 2018 
[cited 2019 Oct 25]. ABS cat. no. 
4364.0.55.001. Available from: https://
www.abs.gov.au/ausstats/
[2] Ogden, C.L., Carroll, M.D., Kit, B.K., 
Flegal, K.M. Prevalence of childhood 
and adult obesity in the United States 
2011-2012. JAMA. 2014; 311, 806-814. 
DOI: 10.1001/jama.2014.732
[3] WHO. 2017. 10 facts on obesity, 
Accessed September 17, 2019. Available 
from: https://www.who.int/features/
factfiles/obesity/en/
[4] Roy Taylor. Insulin Resistance and 
Type 2 Diabetes. Diabetes 2012 Apr; 
61(4):778-779. https://doi.org/10.2337/
db12-0073
[5] Tang, Q ., Li, X., Song, P. and Xu. 
L. Optimal cut-off values for the 
homeostasis model assessment of 
insulin resistance (HOMA-IR) and 
pre-diabetes screening: Developments 
in research and prospects for the future. 
Drug Discoveries & Therapeutics. 
2015; 9(6):380-385. DOI: 10.5582/
ddt.2015.01207
[6] Sharma, S. and Fleming, E. Use of 
HbA1C testing to diagnose pre-diabetes 
in high risk African American children: 
A comparison with fasting glucose 
and HOMA-IR. Diabetes & Metabolic 
Syndrome: Clinical Research & Reviews 
6 (2012): 157-162. DOI: 10.1016/j.
dsx.2012.09.004
[7] Dagmar Horáková, Ladislav 
Štěpánek, Vladimír Janout, Jana 
Janoutová, Dalibor Pastucha, Helena 
Kollárová, Alena Petráková, Lubomír 
Štěpánek, Roman Husár and Karel 
Martiník. Optimal Homeostasis 
Model Assessment of Insulin 
Resistance (HOMA-IR) Cut-Offs: 
A Cross-Sectional Study in the Czech 
Population. Medicina (Kaunas). 
2019 May; 55(5): 158. DOI: 10.3390/
medicina55050158
[8] National Institute for Health and 
Care Excellence. Weight management: 
lifestyle services for overweight or 
obese adults [Internet]. [London]: 
NICE; 2014 [updated May 2017; cited 




[9] M.D. Jensen, D.H. Ryan, C.M. 
Apovian, J.D. Ard, A.G. Comuzzie, 
K.A. Donato, et al.,2013 AHA/ACC/
TOS guideline for the management 
of overweight and obesity in adults: 
a report of the american college of 
cardiology/american heart association 
task force on practice guidelines and the 
obesity society, J Am Coll Cardiol. 63 
(25, Part B) (2014) 2985-3023.
[10] Julia C., Peneau S., Andreeva V.A., 
Mejean C.; Fezeu L., Galan P., Hercberg S. 
Weight-loss strategies used by the general 
population: How are they perceived? 
PLoS ONE 2014, 9, e97834. DOI: 10.1371/
journal.pone.0097834
[11] Jensen M.D., Ryan D.H., 
Apovian C.M., Ard J.D., Comuzzie A.G., 
Donato K.A., Hu F.B., Hubbard V.S., 
Jakicic J.M., Kushner R.F., et al. 2013 
AHA/ACC/TOS guideline for the 
management of overweight and obesity 
in adults: A report of the American 
College of Cardiology/American Heart 
Association Task Force on Practice 
Guidelines and The Obesity Society. 
Circulation 2014, 129, S102–S138. DOI: 
10.1161/01.cir.0000437739.71477.ee
[12] Mattson M.P., Longo V.D., Harvie M. 
Impact of intermittent fasting on health 
and disease processes. Ageing Res. 
Rev. 2017, 39, 46-58. DOI: 10.1016/j.
arr.2016.10.005
References
Type 2 Diabetes - From Pathophysiology to Cyber Systems
16
[13] Ana Luísa and Kremer Faller. 
Impact of intermittent fasting on 
the body weight of overweight and 
obese individuals. http://dx.doi.
org/10.1590/1806-9282.66.2.237
[14] Lukas Schwingshackl, Jasmin 
Zähringer, Kai Nitschke, Gabriel 
Torbahn, Szimonetta Lohner, Tilman 
Kühn, Luigi Fontana, Nicola Veronese, 
Christine Schmucker and Joerg J 
Meerpohl. Impact of intermittent 
energy restriction on anthropometric 
outcomes and intermediate disease 
markers in patients with overweight 
and obesity: systematic review and 
meta analyses. Critical Reviews in Food 
Science and Nutrition. 2020. DOI: 
10.1080/10408398.2020.1757616
[15] Kai Liu, Bo Liu, Leonie K. 
Heilbronn. Intermittent fasting: What 
questions should we be asking? 
Physiology & Behavior 218. 2020. DOI: 
10.1016/j.physbeh.2020.112827
[16] Stephen D. Anton, Stephanie A. 
Lee, William T. Donahoo, Christian 
McLaren, Todd Manini, Christiaan 
Leeuwenburgh and Marco Pahor. The 
Effects of Time Restricted Feeding 
on Overweight, Older Adults: A 
Pilot Study. Nutrients 2019, 11, 1500; 
DOI:10.3390/nu11071500
[17] Surabhi Bhutani, Monica C. 
Klempel, Cynthia M. Kroeger, John F. 
Trepanowski and Krista A. Varady. 
Alternate Day Fasting and Endurance 
Exercise Combine to Reduce Body 
Weight and Favorably Alter Plasma 
Lipids in Obese Humans. Obesity, 
2013, 21, 1370-1379. DOI:10.1002/
oby.20353
[18] Jane Bowen , Emily Brindal, 
Genevieve James-Martin and Manny 
Noakes. Randomized Trial of a High 
Protein, Partial Meal Replacement 
Program with or without Alternate 
Day Fasting: Similar Effects on Weight 
Loss, Retention Status, Nutritional, 
Metabolic, and Behavioral Outcomes. 
Nutrients 2018, 10, 1145; DOI:10.3390/
nu10091145 www.mdpi
[19] S. Carter, P.M. Clifton, J.B. Keogh. 
The effects of intermittent compared 
to continuous energy restriction on 
glycaemic control in type 2 diabetes; a 
pragmatic pilot trial. Diabetes research 
and clinical practice 122 ( 2016 ) 
106-112. http://dx.doi.org/10.1016/j.
diabres.2016.10.010
[20] Sharayah Carter, Peter M. Clifton, 
Jennifer B. Keogh. Effect of Intermittent 
Compared With Continuous Energy 
Restricted Diet on Glycemic Control 
in Patients With Type 2 Diabetes 
A Randomized Noninferiority 
Trial. JAMA Network Open. 
2018;1(3):e180756. DOI:10.1001/
jamanetworkopen.2018.0756
[21] Rachel Leah Taft. Intermittent 
Fasting for Weight Loss: Pros and 
Cons for People with Diabetes. AADE 
in Practice. 2019. Volume: 7 issue: 4, 
page(s): 42-46.
[22] Corey A. Rynders, Elizabeth A. 
Thomas, Adnin Zaman, Zhaoxing Pan, 
Victoria A. Catenacci and Edward L. 
Melanson. Effectiveness of Intermittent 
Fasting and Time-Restricted Feeding 
Compared to Continuous Energy 
Restriction for Weight Loss. Nutrients. 
2019. 14;11(10):2442. DOI: 10.3390/
nu11102442
[23] Victoria A. Catenacci, Zhaoxing 
Pan, Danielle Ostendorf, Sarah 
Brannon, Wendolyn S. Gozansky, 
Mark P. Mattson, Bronwen Martin, 
Paul S. MacLean, Edward L. Melanson, 
and William Troy Donahoo. A 
Randomized Pilot Study Comparing 
Zero-Calorie Alternate-Day Fasting to 
Daily Caloric Restriction in Adults with 
Obesity. Obesity (2016) 24, 1874-1883. 
DOI:10.1002/oby.21581
[24] Samira Eshghinia, Michael 
Gadgevich Gapparov. Effect of Short-
Term Modified Alternate-Day Fasting 
17
Selecting Intermittent Fasting Type to Improve Health in Type 2 Diabetes: A Machine Learning…
DOI: http://dx.doi.org/10.5772/intechopen.95336
on the Lipid Metabolism in Obese 
Women. IRANIAN JOURNAL OF 
DIABETES AND OBESITY, VOLUME 3, 
NUMBER 1, SPRING 2011.
[25] Michelle Louise Headland, Peter 
Marshall Clifton, Jennifer Beatrice 
Keogh. Effect of intermittent compared 
to continuous energy restriction on 
weight loss and weight maintenance 
after 12 months in healthy overweight 
or obese adults. International Journal of 
Obesity (2019) 43:2028-2036. https://
doi.org/10.1038/s41366-018-0247-2
[26] Amy T. Hutchison, Bo Liu, Rachel E. 
Wood, Andrew D. Vincent, Campbell H. 
Thompson, Nathan J. O’Callaghan, 
Gary A. Wittert, and Leonie K. 
Heilbronn. Effects of Intermittent Versus 
Continuous Energy Intakes on Insulin 
Sensitivity and Metabolic Risk in Women 
with Overweight. Obesity (2019) 27, 
50-58. DOI:10.1002/oby.22345.
[27] Hana Kahleova, Lenka Belinova, 
Hana Malinska, Olena Oliyarnyk, 
Jaroslava Trnovska, Vojtech Skop, 
Ludmila Kazdova, Monika Dezortova, 
Milan Hajek, Andrea Tura, Martin 
Hill and Terezie Pelikanova. Eating 
two larger meals a day (breakfast 
and lunch) is more effective than six 
smaller meals in a reduced-energy 
regimen for patients with type 2 
diabetes: a randomised crossover study. 
Diabetologia (2014) 57:1552-1560. DOI 
10.1007/s00125-014-3253-5
[28] Cynthia M Kroeger, John F 
Trepanowski, Monica C Klempel, 
Adrienne Barnosky, Surabhi Bhutani, 
Kelsey Gabel, Krista A Varady. Eating 
behavior traits of successful weight 
losers during 12 months of alternate-
day fasting: An exploratory analysis 
of a randomized controlled trial. Nutr 
Health. 2018 March ; 24(1): 5-10. 
DOI:10.1177/0260106017753487
[29] Iolanda Cioffi, Andrea Evangelista, 
Valentina Ponzo, Giovannino Ciccone, 
Laura Soldati, Lidia Santarpia, Franco 
Contaldo, Fabrizio Pasanisi, Ezio Ghigo 
and Simona Bo. Intermittent versus 
continuous energy restriction on weight 
loss and cardiometabolic outcomes: a 
systematic review and meta-analysis of 
randomized controlled trials. J Transl 
Med. 2018 Dec 24;16(1):371. DOI: 
10.1186/s12967-018-1748-4
[30] Stephanie Welton, Robert Minty, 
Teresa O’Driscoll, Hannah Willms 
Denise Poirier, Sharen Madden and Len 
Kelly. Intermittent fasting and weight 
loss. Canadian Family Physician Vol 66. 
2020.
[31] Patterson and Sears.  
Metabolic Effects of Intermittent 
Fasting. Annu Rev Nutr. 2017 
Aug 21;37:371-393. DOI: 10.1146/
annurev-nutr-071816-064634
[32] Bartosz Malinowski, Klaudia 
Zalewska, Anna Węsierska, Maya M. 
Sokołowska, Maciej Socha, Grzegorz 
Liczner, Katarzyna Pawlak-Osińska and 
Michał Wiciński. Intermittent Fasting in 
Cardiovascular Disorders-An Overview. 
Nutrients. 2019 Mar 20;11(3):673. DOI: 
10.3390/nu11030673
[33] Kavitha Ganesan, Yacob Habboush 
and Senan Sultan. Intermittent Fasting: 
The Choice for a Healthier Lifestyle. 
Cureus. 2018 Jul 9;10(7):e2947. DOI: 
10.7759/cureus.2947
[34] Adrienne R Barnosky, Kristin K 
Hoddy, Terry G Unterman and Krista 
A Varady. Intermittent fasting vs daily 
calorie restriction for type 2 diabetes 
prevention: a review of human findings. 
Transl Res. 2014 Oct;164(4):302-11. 
DOI: 10.1016/j.trsl.2014.05.013
[35] Stephen D. Anton, Keelin Moehl, 
William T. Donahoo, Krisztina Marosi, 
Stephanie A. Lee, Arch G. Mainous, 
Christiaan Leeuwenburgh, and Mark P. 
Mattson. Flipping the Metabolic Switch: 
Understanding and Applying the Health 
Benefits of Fasting. Obesity. 2017. 
DOI:10.1002/oby.22065
Type 2 Diabetes - From Pathophysiology to Cyber Systems
18
[36] Shula Shazman. A Machine 
Learning Approach to Select the 
Type of Intermittent Fasting in 
Order to Improve Health by Effects 
on Type 2 Diabetes. Conference: 
11th International Conference on 
Bioinformatics Models, Methods and 
Algorithms. Bioinformatics 2020. DOI: 
10.5220/0008950201310137
[37] International Diabetes Federation 
2017. Diabetes Atlas 8th edition.
[38] McCulloch DK, Nathan DM, 
Wolfsdorf JI, Mulder JE, eds. Estimation 
of blood glucose control in diabetes 
mellitus. Wolters Kluwer Health. 
Accessed at: www.uptodate.com. 2013. 
-- 2. A1C test and diabetes. National 
Diabetes Information Clearinghouse 
(NDIC). Available at: http://diabetes.
niddk.nih.gov/dm/pubs/A1CTest/
A1C_Test_DM_508.pdf. Accessed 
011414. -- 3. American Diabetes 
Association. Standards of Medical 
Care in Diabetes—2014. Diabetes Care 
2014;37:S14-S80.
[39] Levy J. C, Matthews D. R, 
Hermans M.P. Correct homeostasis 
model assessment (HOMA) evaluation 
uses the computer program. Diabetes 
Care 1998; 21: 2191-92. DOI: 10.2337/
diacare.21.12.2191
[40] HOMA2 Calculator. Oxford 
University. Available at: https://www.
dtu.ox.ac.uk/homacalculator/download.
php
[41] Heilbronn L.K, Smith S.R, 
Martin C.K, Anton S.D. and Ravussin E. 
Alternate-day fasting in nonobese 
subjects: effects on body weight, body 
composition, and energy metabolism. 
Am. J. Clin. Nutr. 81 (1) (2005) 69-73. 
DOI: 10.1093/ajcn/81.1.69
[42] Harvie M.N, Pegington M, 
Mattson M.P, Frystyk J, Dillon B, Evans G, 
Cuzick J, Jebb S.A, Martin B, Cutler R.G, 
Son T.G, Maudsley S, Carlson O.D, 
Egan J.M, Flyvbjerg A. and Howell A. 
The effects of intermittent or continuous 
energy restriction on weight loss and 
metabolic disease risk markers: a 
randomized trial in young overweight 
women. International Journal of Obesity 
(2011) 35, 714-727. DOI: 10.1038/
ijo.2010.171
[43] Schofield W.N. Predicting basal 
metabolic rate, new standards and 
review of previous work. Hum Nutr Clin 
Nutr 1985; 39 (Suppl 1): 5-41.
[44] Shai I, Schwarzfuchs D, Henkin Y, 
Shahar DR, Witkow S, Greenberg I et 
al. Weight loss with a low-carbohydrate, 
Mediterranean, or low-fat diet. N Engl J 
Med 2008; 359: 229-241. DOI: 10.1056/
NEJMoa0708681
[45] Chowdhury E.A, 
Richardson J.D, Holman G.D, 
Tsintzas K, Thompson D. and Betts J.A. 
The causal role of breakfast in energy 
balance and health: a randomized 
controlled trial in obese adults. Am J 
Clin Nutr. 2016 Mar;103(3):747-56. DOI: 
10.3945/ajcn.115.122044
[46] Halberg N, Morten H, 
Nathalie S, Bente S, Thorkil P, Peter S 
and Flemming D. Effect of intermittent 
fasting and refeeding on insulin 
action in healthy men. J Appl Physiol 
99: 2128-2136, 2005. DOI:10.1152/
japplphysiol.00683
[47] Harvie M, Wright C, Pegington M, 
McMullan D, Mitchell E, Martin B, 
Cutler R.G, Evans G, Whiteside S, 
Maudsley S, Camandola S, Wang R, 
Carlson O.D, Egan J.M, Mattson M.P. 
and Howell A. The effect of intermittent 
energy and carbohydrate restriction v. 
daily energy restriction on weight loss 
and metabolic disease risk markers in 
overweight women. British Journal 
of Nutrition (2013), 110, 1534-1547. 
DOI:10.1017/S0007114513000792
[48] Clifton P. M., Noakes M. and 
Keogh J. B. 2004. Very Low-Fat (12%) 
and High Monounsaturated Fat (35%) 
19
Selecting Intermittent Fasting Type to Improve Health in Type 2 Diabetes: A Machine Learning…
DOI: http://dx.doi.org/10.5772/intechopen.95336
Diets Do Not Differentially Affect 
Abdominal Fat Loss in Overweight, 
Nondiabetic Women. Very Low-Fat 
(12%) and High Monounsaturated 
Fat (35%) Diets Do Not Differentially 
Affect Abdominal Fat Loss in 
Overweight, Nondiabetic Women. 
J Nutr. 2004 Jul;134(7):1741-5. DOI: 
10.1093/jn/134.7.1741
[49] IDF Diabetes Care. Volume 42, 
Supplement 1, January 2019.
[50] Sewaiwar P. and Verma K.K. 
Comparative Study of Various Decision 
Tree Classification Algorithm 
Using WEKA. International Journal 
of Emerging Research in Management 
&Technology 2015. ISSN: 2278-9359 
(Volume- 4, Issue-10) .
[51] Hua J., Xiong Z., Lowey J., Suh E. 
and Dougherty E. R. Optimal number 
of features as a function of sample 
size for various classification rules. 
Bioinformatics. 2004. 21(8):1509-15. 
DOI: 10.1093/bioinformatics/bti171
